Well, we're believers that through the downturn there's quite clear evidence that a lot of companies have, one, shrunk in size. We've taken a lot of small companies public. So there is a landscape that is fairly fragmented, particularly as it relates to support of our customers in lower 48. So given that, I do think with the progression of time people are going to find that scale is needed, particularly to return companies back to healthy returns, i.e., that old caveat of returns on invested capital should appear, right. And I think we've been challenged to do that fairly organically just because we've had such difficult headwinds with the market downturn over the last three years. So M&A is going to continue to be a focus. We have always, throughout our history, been able to fund organic growth. And so there's no reason to think that changes. And that's always our first capital allocation priority. I believe our CapEx guidance, I'm looking at Lloyd, it's $75 million to $80 million for the year. If the market continues to expand we might lever, but that would be the first thing that we would kind of lever upward if there's reason and economic results from doing so. Look, we always say M&A is in our DNA so to speak. I think, well, number one, we do it well. We know how to value transactions, close them, integrate them, and get the results that we're looking for. That being said, we're digesting what we have. We're making sure that we do that efficiently, and smoothly, and get the intended results from those two acquisitions. We did take on some debt in connection with those acquisitions, but a lot of that centers in the convert that we issued. And we did that intentionally to allow some pre-payable debt under our revolving credit facility. So it is my expectation that without M&A we'll be dedicating that free cash flow to debt repayment in the near-term. And again, continue to be opportunistic and see what we can do to enhance the returns to our shareholders.